Trials / Completed
CompletedNCT02013934
Probiotics in Prevention of Common Cold
Benefit and Tolerability of a Probiotic Product in Subjects With Increased Susceptibility to Common Cold
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 899 (actual)
- Sponsor
- Probi AB · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to assess the benefit and tolerability of a probiotic product in subjects with increased susceptibility to common cold.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-17
- First posted
- 2013-12-17
- Last updated
- 2018-04-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02013934. Inclusion in this directory is not an endorsement.